bevacizumab

Cancer Research Roundup: Child Care and Treatment, IBD-associated Colorectal Cancer, Ibrutinib, and Glioblastoma

March 14, 2014

The latest roundup of cancer research from UChicago highlights: a study showing how young mothers with breast cancer often don't follow through with needed radiation therapy; a link between inflammatory bowel disease and colorectal cancer; Ibrutinib's work at limiting cell proliferation in chronic lymphocytic leukemia; a prognostic tool for neuroblastoma; and testing bevacizumab in glioblastoma. [Read more]

What’s New In Neuro-Oncology: A CME Presentation

October 18, 2013

For many physicians, having to tell a long-time patient they have brain cancer can be difficult. The patient has many preconceived notions, and the physician's recollections of treatment modalities may be dated. We hosted a continuing medical education evening to update physicans on infiltrating gliomas, the second most common form of brain tumor. [Read more]

Avastin for Glioblastomas: Where Do We Go After the Results of RTOG 0825?

July 22, 2013

We have tried almost everything to treat glioblastoma without much progress. For the last 10 years, the treatment for malignant glioma has remained the same: surgery, if possible, followed by radiation and temozolomide, an oral alkylating agent. Recently, bevacizumab (Avastin) has risen in prominence for the treatment of recurrent glioblastoma. A recent study, though, suggests it will not likely be adopted in initial treatments. [Read more]